Investor relations

ÐǺ£ÆåÅÆ at a glance

ÐǺ£ÆåÅÆ is an international biotechnology company that develops innovative antibody products to transform the treatment of cancer and other serious diseases.
A woman wearing glasses smiles warmly at a man sitting at a table.A woman wearing glasses smiles warmly at a man sitting at a table.

ÐǺ£ÆåÅÆ ÐǺ£ÆåÅÆ

ÐǺ£ÆåÅÆ aims to improve people’s lives with antibody therapeutics. Through next-generation technology platforms, transactional research and data sciences, it has created a pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates.

To help develop and deliver novel antibody therapies to patients, ÐǺ£ÆåÅÆ has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030 ÐǺ£ÆåÅÆ's vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO®) antibody medicines.

How we operate

Diagram outlining ÐǺ£ÆåÅÆ’s operational strategy of research, development and commercialization and values of team, strong financials, collaboration and translational research and data science
Our global presence
A brick building with green tinted windows, showcasing a blend of traditional and modern architecture.
Copenhagen, DK
  • Headquarters
  • CMC Operations
  • Clinical Operations
  • Corporate Functions
A spacious room featuring a bench and lush raised garden, creating a serene ambiance
Tokyo, JP
  • Japan Clinical
  • Japan Market Operations
  • Corporate Functions
Open office space with wooden ceiling and chairs, creating a warm and professional atmosphere
Princeton, US
  • Translational Research
  • Development
  • US Market Operations
  • Corporate Functions
People walk around a bustling modern atrium, creating a vibrant and lively atmosphere
Utrecht, NL
  • Research
  • Translational Research
  • Antibody Product Creation
  • Corporate Functions
Our strengths & differentiators
World-class knowledge
We have world-class antibody biology knowledge and deep insight into disease targets.
Discovery and development engine
Our discovery and development engine features proprietary technologies that allow us to build a world-class pipeline.
In-house expertise
Our experts have a solid track record of building successful strategic partnerships.
Pipeline
ÐǺ£ÆåÅÆ’s pipeline features potential best-in-class and first-in-class therapies.
Experienced, diverse leadership team
Our senior leaders bring their combined know-how to guide the company’s continued growth trajectory.
Operational stats
8
Approved medicines including ÐǺ£ÆåÅÆ’s innovation (2 therapies co-marketed by ÐǺ£ÆåÅÆ and partners, 6 out-licensed products marketed by partners)
4
Proprietary technologies
9
Proprietary antibody products in clinical development (7 jointly developed with partners, for details click here)
40+
Cumulative INDs since 1999
Explore Further
Low-angle view of the mirrored glass exterior of the ÐǺ£ÆåÅÆ office building in Utrecht, Netherlands.

News & Insights

Find updates, articles and access media from ÐǺ£ÆåÅÆ.

A person riding their bike in front of an office building with large glass windows.

Sustainability & ESG

Learn about ÐǺ£ÆåÅÆ’s commitment to sustainability and the company’s environmental, social and governance commitments and performance.